The metastatic capacity of breast carcinoma cells expressing HuR was related to the secretion of CC chemokine ligand 2 (CCL2), a small cytokine with pro-tumorigenic and angiogenic effects that has been implicated in various metastatic processes, including bone metastasis (Lee et al., 2017). This evidence concerns the gene ELAVL1 and breast carcinoma.